{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:23:32Z","timestamp":1778689412411,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1987,9,1]],"date-time":"1987-09-01T00:00:00Z","timestamp":557452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1987,9]]},"DOI":"10.1007\/bf02439593","type":"journal-article","created":{"date-parts":[[2006,7,27]],"date-time":"2006-07-27T22:20:38Z","timestamp":1154038838000},"page":"94-100","source":"Crossref","is-referenced-by-count":72,"title":["Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities"],"prefix":"10.1007","volume":"93","author":[{"given":"S.","family":"Mithani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Atmadja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. G.","family":"Baimbridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. C.","family":"Fibiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02439593_CR1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0021-9258(18)70204-4","volume":"234","author":"RW Albers","year":"1959","unstructured":"Albers RW, Brady RO (1959) The distribution of glutamate decarboxylase in the nervous system of the rhesus monkey. J Biol Chem 234:926\u2013928","journal-title":"J Biol Chem"},{"key":"BF02439593_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0014-2999(80)90480-X","volume":"62","author":"J Arnt","year":"1980","unstructured":"Arnt J, Scheel-Kr\u00fcger J (1980) Intranigral GABA antagonists produce dopamine-independent biting in rats. Eur J Pharmacol 62:51\u201361","journal-title":"Eur J Pharmacol"},{"key":"BF02439593_CR3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0006-8993(82)90526-1","volume":"239","author":"KG Baimbridge","year":"1982","unstructured":"Baimbridge KG, Parkes CO, Miller JJ (1982) Calcium-binding protein distribution in the rat brain. Brain Res 239:519\u2013525","journal-title":"Brain Res"},{"key":"BF02439593_CR4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248\u2013254","journal-title":"Anal Biochem"},{"key":"BF02439593_CR5","first-page":"376","volume":"20","author":"DE Casey","year":"1984","unstructured":"Casey DE (1984) Tardive dyskinesia \u2014 animal models. Psychopharmacol Bull 20:376\u2013379","journal-title":"Psychopharmacol Bull"},{"key":"BF02439593_CR6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/978-3-642-70140-5_11","volume-title":"Dyskinesia research and treatment","author":"DE Casey","year":"1985","unstructured":"Casey DE (1985) Tardive dyskinesia: reversible and irreversible. In: Casey DE, Chase TN, Christensen TR, Gerlach J (eds) Dyskinesia research and treatment. Psychopharmacology [Suppl 2]. Springer, Berlin Heidelberg New York, pp 88\u201397"},{"key":"BF02439593_CR7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00432375","volume":"70","author":"DE Casey","year":"1980","unstructured":"Casey DE, Gerlach J, Christensson E (1980) Dopamine, acetylcholine and GABA effects in acute dystonia in primates. Psychopharmacology 70:83\u201387","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00432565","volume":"76","author":"DM Coward","year":"1982","unstructured":"Coward DM (1982) Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam. Psychopharmacology 76:294\u2013298","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00437417","volume":"37","author":"WE Fann","year":"1974","unstructured":"Fann WE, Lake CR, Gorber CJ, McKenzie GM (1974) Cholinergic suppression of tardive dyskinesia. Psychopharmacology 37:101\u2013107","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.1975.tb11895.x","volume":"24","author":"F Fonnum","year":"1975","unstructured":"Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyl transferase. J Neurochem 24:407\u2013409","journal-title":"J Neurochem"},{"key":"BF02439593_CR11","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.82.24.8780","volume":"82","author":"CR Gerfen","year":"1985","unstructured":"Gerfen CR, Baimbridge KG, Miller JJ (1985) The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci USA 82:8780\u20138784","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF02439593_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00426516","volume":"69","author":"RB Glassman","year":"1980","unstructured":"Glassman RB, Glassman HN (1980) Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology 69:19\u201325","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF00427260","volume":"81","author":"L-M Gunne","year":"1983","unstructured":"Gunne L-M, Haggstrom J-E (1983) Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology 81:191\u2013194","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/BF00431935","volume":"77","author":"L-M Gunne","year":"1982","unstructured":"Gunne L-M, Growdon J, Glaeser B (1982) Oral dyskinesias in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77:134\u2013139","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/309347a0","volume":"309","author":"L-M Gunne","year":"1984","unstructured":"Gunne L-M, Haggstrom J-E, Sjoquist B (1984) Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA-synthesis. Nature 309:347\u2013349","journal-title":"Nature"},{"key":"BF02439593_CR16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-1019530","volume":"15","author":"J-E Haggstrom","year":"1981","unstructured":"Haggstrom J-E, Anderson U, Gunne L-M (1981) Bromocriptine in tardive dyskinesia. Pharmacopsychiatria 15:161\u2013163","journal-title":"Pharmacopsychiatria"},{"key":"BF02439593_CR17","unstructured":"Horton RW, Jenner P, Marsden CD, Prestwich SA, Rupniak NMJ (1985) Alterations in cerebral GABA parameters following treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine. Br J Pharmacol 86:472P"},{"key":"BF02439593_CR18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/194495a0","volume":"194","author":"WM Hunter","year":"1962","unstructured":"Hunter WM, Greenwood FC (1962) Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495\u2013496","journal-title":"Nature"},{"key":"BF02439593_CR19","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0024-3205(77)90204-1","volume":"21","author":"KG Lloyd","year":"1977","unstructured":"Lloyd KG, Hornykiewicz O (1977) Effect of chronic neuroleptic orl-dopa administration on GABA levels in the rat substantia nigra. Life Sci 21:1489\u20131496","journal-title":"Life Sci"},{"key":"BF02439593_CR20","first-page":"308","volume-title":"GABA-neurotransmitters","author":"KG Lloyd","year":"1979","unstructured":"Lloyd KG, Worms P, Depoortere H, Bartholini G (1979) Pharmacological profile of SL 76002, a new GABA-mimetic drug. In: Korsgaard-Larsen P, Scheel-Kr\u00fcger J, Kofod H (eds) GABA-neurotransmitters. Munksgaard, Copenhagen, pp 308\u2013312"},{"key":"BF02439593_CR21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall AJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:259\u2013265","journal-title":"J Biol Chem"},{"key":"BF02439593_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0006-8993(71)90334-9","volume":"32","author":"PL McGeer","year":"1971","unstructured":"McGeer PL, McGeer EG, Wada JA, Jung E (1971) Effects of globus pallidus lesions and parkinson's disease on brain glutamic acid decarboxylase. Brain Res 32:425\u2013431","journal-title":"Brain Res"},{"key":"BF02439593_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0006-8993(77)90431-0","volume":"132","author":"CC Mao","year":"1977","unstructured":"Mao CC, Cheney DL, Marco E, Revuelta A, Costa E (1977) Turnover times of gamma-butyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: effects of repeated administration of haloperidol. Brain Res 132:375\u2013379","journal-title":"Brain Res"},{"key":"BF02439593_CR24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0028-3908(78)90153-3","volume":"17","author":"E Marco","year":"1978","unstructured":"Marco E, Mao CC, Revuelta A, Peralta E, Costa E (1978) Turnover rates of \u03c4-aminobutyric acid in substantia nigra, n. caudatus, globus pallidus and n. accumbens of rats injected with cataleptogenic and noncataleptogenic antipsychotics. Neuropharmacology 17:589\u2013596","journal-title":"Neuropharmacology"},{"key":"BF02439593_CR25","first-page":"1556","volume":"135","author":"NPV Nair","year":"1980","unstructured":"Nair NPV, Yassa R, Ruiz-Nararro J, Schwartz G (1980) Baclofen in the treatment of tardive dyskinesia. Am J Psychiatry 135:1556\u20131663","journal-title":"Am J Psychiatry"},{"key":"BF02439593_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0278-5846(83)90102-1","volume":"7","author":"SK Rastogi","year":"1983","unstructured":"Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD (1983) Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined. Prog Neuro-Psychopharmacol Biol Psychiatry 7:153\u2013164","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"BF02439593_CR27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00427817","volume":"79","author":"NMJ Rupniak","year":"1983","unstructured":"Rupniak NMJ, Jenner P, Marsden CD (1983) Cholinergic manipulation of perioral behavior induced by chronic neuroleptic administration to rats. Psychopharmacology 79:226\u2013230","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00427326","volume":"85","author":"NMJ Rupniak","year":"1985","unstructured":"Rupniak NMJ, Jenner P, Marsden CD (1985) Pharmacological characterization of spontaneous or drug associated purposeless chewing movements in rats. Psychopharmacology 85:71\u201379","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR29","first-page":"16","volume":"14","author":"GM Simpson","year":"1978","unstructured":"Simpson GM, Lee JH, Shrivastava RK, Branchey MH (1978) Baclofen in the treatment of tardive dyskinesia and schizophrenia. Psychopharmacol Bull 14:16\u201318","journal-title":"Psychopharmacol Bull"},{"key":"BF02439593_CR30","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0006-3223(85)90214-8","volume":"20","author":"SM Stahl","year":"1985","unstructured":"Stahl SM, Thornton JE, Simpson ML, Berger PA, Napoliello J (1985) Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders. Biol Psychiatry 20:888\u2013893","journal-title":"Biol Psychiatry"},{"key":"BF02439593_CR31","first-page":"746","volume":"36","author":"CA Tamminga","year":"1979","unstructured":"Tamminga CA, Crayton JW, Chase TN (1979) Improvement in tardive dyskinesia after muscimol therapy. Am J Psychiatry 36:746\u2013747","journal-title":"Am J Psychiatry"},{"key":"BF02439593_CR32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(83)90075-2","volume":"II","author":"CA Tamminga","year":"1983","unstructured":"Tamminga CA, Thaker GK, Ferraro TN, Hare TA (1983) GABA agonist treatment improves tardive dyskinesia. Lancet II:97\u201398","journal-title":"Lancet"},{"key":"BF02439593_CR33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/BF00690944","volume":"91","author":"JL Waddington","year":"1987","unstructured":"Waddington JL, Molloy AG (1987) The status of late-onset vacuous chewing\/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia? Psychopharmacology 91:136\u2013137","journal-title":"Psychopharmacology"},{"key":"BF02439593_CR34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.6132447","volume":"220","author":"JL Waddington","year":"1983","unstructured":"Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220:530\u2013532","journal-title":"Science"},{"key":"BF02439593_CR35","first-page":"321","volume-title":"Nomenclature of the Vitamin D induced calcium-binding proteins","author":"RH Wasserman","year":"1985","unstructured":"Wasserman RH (1985) Nomenclature of the Vitamin D induced calcium-binding proteins. In: Norman AW (ed) Vitamin D. de Gruyter, Berlin, pp 321\u2013323"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02439593.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02439593\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02439593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T13:49:09Z","timestamp":1627652949000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02439593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,9]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1987,9]]}},"alternative-id":["BF02439593"],"URL":"https:\/\/doi.org\/10.1007\/bf02439593","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,9]]}}}